🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

20+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 20 recruiting trials for “dermatopathia-pigmentosa-reticularis

RecruitingNCT07502664

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

🏥 Ray Therapeutics, Inc.📍 1 site📅 Started Feb 2026View details ↗
NARecruitingNCT07292987

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

👨‍⚕️ Isabelle Audo, Pr, CRMR Centre Hospitalier National D' Ophtalmologie Des Quinze-Vingts📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07228793

Natural History Study of Patients With EYS-Associated RP

👨‍⚕️ Marianna Weener, MD, PhD, Oftalmic📍 1 site📅 Started Nov 2025View details ↗
Phase 1, PHASE2RecruitingNCT06891885

A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

🏥 Sumitomo Pharma America, Inc.📍 1 site📅 Started Oct 2025View details ↗
Phase 2RecruitingNCT07174726

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

👨‍⚕️ None None📍 6 sites📅 Started Sep 2025View details ↗
Phase 2RecruitingNCT06628947

A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa

👨‍⚕️ Doron Hickey, MBChB, The Centre for Eye Research Australia (CERA)📍 5 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06912633

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

👨‍⚕️ Henry Klassen, MD, PhD, jCyte, Inc📍 14 sites📅 Started Jun 2025View details ↗
RecruitingNCT06982417

InsightRP2 Registry

🏥 University of Göttingen📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06627179

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

🏥 Laboratoires Thea📍 27 sites📅 Started Dec 2024View details ↗
Phase 1, PHASE2RecruitingNCT06787482

Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies

👨‍⚕️ Dr. Passant Sayed Saif, PhD ophthalmology, Associate prof of Ophthalmology Misr University for science and technology📍 2 sites📅 Started Nov 2024View details ↗
NAEnrolling by InvitationNCT07088705

Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa

🏥 Marta P. Wiącek📍 1 site📅 Started Sep 2024View details ↗
Phase 1, PHASE2RecruitingNCT06242379

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

👨‍⚕️ Laongsri Atchaneeyasakul, Professor, Mahidol University📍 1 site📅 Started May 2024View details ↗
Phase 1, PHASE2RecruitingNCT06492850

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

👨‍⚕️ Ruifang Sui, Peking Union Medical College Hospital📍 1 site📅 Started Apr 2024View details ↗
Phase 2Enrolling by InvitationNCT06275620

A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)

🏥 Beacon Therapeutics📍 7 sites📅 Started Nov 2023View details ↗
NARecruitingNCT05853107

Pilot Study of AuTNA I

👨‍⚕️ Chunhui Jiang, Eye and ENT Hospital of Fudan University📍 1 site📅 Started May 2023View details ↗
EARLY_Phase 1RecruitingNCT05874310

Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa

👨‍⚕️ Gezhi Xu, Eye & ENT Hospital of Fudan University📍 2 sites📅 Started Feb 2023View details ↗
Phase 1, PHASE2RecruitingNCT04278131

BS01 in Patients With Retinitis Pigmentosa

👨‍⚕️ Sheila Nirenberg, PhD, Bionic Sight LLC📍 1 site📅 Started Feb 2020View details ↗
RecruitingNCT04639635

CNGB1 and Allied Disorders

👨‍⚕️ Stephen Tsang, MD, PhD, Columbia University📍 6 sites📅 Started Mar 2019View details ↗
NARecruitingNCT03635645

Experimental and Clinical Studies of Retinal Stimulation

👨‍⚕️ James Weiland, University of Michigan📍 1 site📅 Started Oct 2017View details ↗
RecruitingNCT00254605

Retinal Imaging in Patients With Inherited Retinal Degenerations

👨‍⚕️ Jacque L. Duncan, M.D., University of California, San Francisco📍 1 site📅 Started Nov 2005View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →